The majority (60–70 %) of patients with DOA harbour pathogenic mutations in the nuclear gene OPA1 that encodes for a mitochondrial inner membrane protein with multifunctional properties [4, 47]. The gene discussed is IMMT; the disease is autosomal dominant optic atrophy.